Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections
About a quarter of the world’s population is infected with <i>Mycobacterium tuberculosis</i>. Growing antibiotic resistance by this microorganism is a major problem in the therapy of the disease. <i>M. avium-M. intracellulare</i> that emerged as a major opportunistic infectio...
Saved in:
Main Authors: | Metin Yıldırım, Nejat Düzgüneş |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/7/728 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposomes used in the delivery of various antimicrobials to biofilm-producing infections: a systematic review
by: Manouchehr Teymouri, et al.
Published: (2025-04-01) -
Insights into Natural Products from Marine-Derived Fungi with Antimycobacterial Properties: Opportunities and Challenges
by: Muhammad Azhari, et al.
Published: (2025-07-01) -
Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV
by: Davood Mansury, et al.
Published: (2019-12-01) -
Assessment of Antimycobacterial Activity of Newly Synthesized Pyrimidine Derivatives Against Mycobacterium tuberculosis
by: M. A. Samotrueva, et al.
Published: (2022-08-01) -
Development of Liposomal Forms of Modified Pyrimidine Nucleosides and Investigation of Their Antibacterial Properties
by: I. L. Karpenko, et al.
Published: (2020-05-01)